RecruitingNot ApplicableNCT07357090

Carbon Dioxide Administration and Brain Waste Clearance

Mechanisms Underlying Carbon Dioxide Induced Protein Efflux in Health and Traumatic Brain Injury


Sponsor

Andrew Mayer

Enrollment

200 participants

Start Date

Apr 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The current study tests whether different exposures to carbon dioxide (CO2) can safely result in the increased movement of proteins from the brain into the blood. The investigators believe that this would be a proxy for the brain clearing waste products more effectively. The current study will use a counter-balanced design, in which individuals with and without a history of traumatic brain injury (TBI) will receive different levels of CO2 (targeted changes of approximately 5 or 10 mmHG in end-tidal CO2) approximately one week apart. The counter-balanced design means that each participant receives a single dose of CO2 at each visit, and different doses of CO2 at each visit. The order in which participants receive the dose is randomized, and the participant will not be informed of the dose.


Eligibility

Min Age: 18 YearsMax Age: 82 Years

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERHypercapnia task performed during fMRI

This study looks at different levels of carbon dioxide (CO2) exposure (changes of approximately 5 or 10 mmHg) on the brain and proteins in blood, in response to a hypercapnia task while participants undergo MRI. This sequence will dynamically mix gases to target an increase of 5 or 10 mmHg in ETCO2 (increase of \~5-7% CO2 and equal decrease in nitrogen) while keeping O2 constant.


Locations(1)

The Mind Research Network

Albuquerque, New Mexico, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07357090


Related Trials